These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A serological survey for cholera antibodies in rural east Pakistan. 2. A comparison of antibody titres in the innunized and control populationd of a cholera-vaccine field-trial area and the relation of antibody titre to cholera case rate. Mosley WH, Benenson AS, Barui R. Bull World Health Organ; 1968; 38(3):335-46. PubMed ID: 5302923 [Abstract] [Full Text] [Related]
4. Serological studies in cholera. 3. Serum toxin neutralization--rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population of East Pakistan. Benenson AS, Saad A, Mosley WH, Ahmed A. Bull World Health Organ; 1968; 38(2):287-95. PubMed ID: 5302304 [Abstract] [Full Text] [Related]
5. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Mosley WH, Ahmad S, Benenson AS, Ahmed A. Bull World Health Organ; 1968; 38(5):777-85. PubMed ID: 5303331 [Abstract] [Full Text] [Related]
6. Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. 3. The lack of effect of prior vaccination or circulating vibriocidal antibody on the severity of clinical cholera. McCormack WM, Rahman AS, Chowdhury AK, Mosley WH, Phillips RA. Bull World Health Organ; 1969; 40(2):199-204. PubMed ID: 5306540 [Abstract] [Full Text] [Related]
7. Report of the 1966-67 cholera vaccine trial in rural East Pakistan. Mosley WH, Aziz KM, Mizanur Rahman AS, Alauddin Chowdhury AK, Ahmed A, Fahimuddin M. Bull World Health Organ; 1972; 47(2):229-38. PubMed ID: 4539414 [Abstract] [Full Text] [Related]
8. Cholera vaccine field trials in east Pakistan. 2. Effectiveness in the field. Benenson AS, Mosley WH, Fahimuddin M, Oseasohn RO. Bull World Health Organ; 1968; 38(3):359-72. PubMed ID: 5302329 [Abstract] [Full Text] [Related]
11. [Value of vibriocidal antibody research in endemic areas of Vibrio cholerae 0:1]. Bendib A, Bougoudogo F, Messast M, Rezkallah D, Hamchi L, Bellouche Y, Aidoud NS, Keddouri A, Fournier JM, Dodin A. Bull Soc Pathol Exot; 1994; 87(1):33-7. PubMed ID: 8003902 [Abstract] [Full Text] [Related]
13. Characteristics of the serum vibriocidal and agglutinating antibodies in cholera cases and in normal residents of the endemic and non-endemic cholera areas. Ahmed A, Bhattacharjee AK, Mosley WH. J Immunol; 1970 Aug; 105(2):431-41. PubMed ID: 5433700 [No Abstract] [Full Text] [Related]
16. Field trials of monovalent Ogawa and Inaba cholera vaccines in rural Bangladesh--three years of observation. Mosley WH, Aziz KM, Rahman AS, Chowdhury AK, Ahmed A. Bull World Health Organ; 1973 Aug; 49(4):381-7. PubMed ID: 4604478 [Abstract] [Full Text] [Related]
17. [Studies on the efficacy of cholera vaccination in a population sample of Bari]. Barbuti S, Iandolo E, Leogrande G, Rizzo G, Jatta E, Di Bari C. Ann Sclavo; 1975 Aug; 17(3):489-99. PubMed ID: 1230049 [Abstract] [Full Text] [Related]
18. Safety and immunogenicity of oral killed whole cell recombinant B subunit cholera vaccine in Barranquilla, Colombia. Concha A, Giraldo A, Castañeda E, Martínez M, de la Hoz F, Rivas F, Depetris A, Svennerholm AM, Sack DA. Bull Pan Am Health Organ; 1995 Dec; 29(4):312-21. PubMed ID: 8605522 [Abstract] [Full Text] [Related]
19. Serological studies in cholera. 2. The vibriocidal antibody response of cholera patients determined by a microtechnique. Benenson AS, Saad A, Mosley WH. Bull World Health Organ; 1968 Dec; 38(2):277-85. PubMed ID: 5302303 [Abstract] [Full Text] [Related]